NEWS
2025.10.28
Veritas In Silico to Participate in The 42nd Medicinal Chemistry Symposium
Our company will participate in The 42nd Medicinal Chemistry Symposium featuring AI x Drug Discovery, to be held from November 18 (Tuesday) to November 20 (Thursday), 2025, at Awagin Hall in Tokushima City.
Our researcher, Koji Imai, will be actively contributing to the symposium with a short oral presentation and a poster discussion. We encourage all attendees to attend Mr. Imai’s sessions to learn about our latest research. Additionally, our company will host an exhibition booth at the venue on November 18 (Tuesday) and 19 (Wednesday). We invite you to stop by our booth to discuss our work and explore potential collaborations.
We look forward to meeting you at the symposium!
Related Links:
The 42nd Symposium on Medicinal Chemistry: https://www.k-gakkai.jp/mcs2025/en/en_index.html
Symposium Program: https://www.k-gakkai.jp/mcs2025/en/en_program.html
The details of Koji’s presentation are as follows:
■ Short Oral Presentation 1
Date and time: Tuesday, November 18, 16:40-17:50
Presentation number: 1P-27
Title: Design of high-affinity RNA binders using an FMO-calculation-based DMTA cycle
Presenter: Imai Koji
■ Poster Discussion 1
Date and time: Thursday, November 18, 17:50-19:30
Presentation Number: 1P-27
Title: Design of high-affinity RNA binders using an FMO-calculation-based DMTA cycle
Presenter: Imai Koji